SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA concludes inspection at Jubilant Pharmova’s arm’s facility in U.S.A

19 Jun 2026 Evaluate

United States Food and Drug Administration (USFDA) has concluded an inspection at Jubilant Pharmova’s wholly owned subsidiary -- Jubilant HollisterStier LLC's (JHS) contract manufacturing facility located in Spokane, WA. U.S.A on June 17, 2026. The USFDA had issued 8 observations, none of which are related to sterility assurance concerns. 

JHS will respond to the inspection observations within 15 business days. The company is committed to addressing the observations comprehensively.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

974.10 1.45 (0.15%)
03-Jul-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1919.00
Dr. Reddys Labs. 1370.00
Cipla 1460.00
Zydus Lifesciences 1118.00
Lupin 2465.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: